Following a review by the TGA, medicines and other therapeutic goods can be suspended from the Australian Register of Therapeutic Goods. For listed and registered medicines, these suspensions are made by the Secretary under section 29D of the Therapeutic Goods Act 1989 (the Act).
If a suspension occurs because of a safety concern, the TGA considers whether other actions including a recall are necessary and takes those actions when required. Any safety-related actions will appear under 'Further information'.
The reasons for a suspension are stated in the database under 'Grounds for suspension'.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.